Clinical Trials Directory

Trials / Completed

CompletedNCT02819700

Evaluation and Characterization of Behavioural Disorders and Dementias by the Behavioural Dysexecutive Syndrome Inventory (BDSI)

Status
Completed
Phase
Study type
Observational
Enrollment
49 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Behavioural disorders are very common right from the initial stage of dementia and contribute to loss of autonomy. Behavioural dysexecutive disorders have a particular status due to their prevalence and their diagnostic importance, as they often constitute the initial symptoms of Frontotemporal Dementia (FTD), Semantic Dementia (SD) and Huntington's disease (HD) and they are classically more frequent in vascular dementia (VaD) than in Alzheimer's disease (AD). The presence of these disorders at the stage of Mild Cognitive Impairment (MCI) has only been partially evaluated and would increase the risk of progression to dementia. These classical data are based on non-standardized assessments and non-validated diagnostic criteria. The Groupe de Reflexion pour l'Evaluation des Fonctions EXécutives (GREFEX) has developed a standardized assessment tool for behavioural dysexecutive disorders, the Behavioural Dysexecutive Syndrome Inventory (BDSI) and has validated diagnostic criteria for this syndrome.

Conditions

Interventions

TypeNameDescription
BEHAVIORALprevalence of behavioural dysexecutive syndromeBehavioural Dysexecutive Syndrome Inventory (ISDC)

Timeline

Start date
2013-01-29
Primary completion
2018-01-28
Completion
2018-01-28
First posted
2016-06-30
Last updated
2020-07-20

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02819700. Inclusion in this directory is not an endorsement.